Library›Organic chemistry and synthesis›Yeast Terpenes and Biosynthesis

Yeast Terpenes and Biosynthesis

Yeast terpenes are terpenes made by, or released by, yeast rather than harvested from a plant. There are two quite different things people mean by the phrase, and they are worth separating because they involve different chemistry and different stakes. The first is biotransformation — yeast, during ordinary fermentation, releasing and modifying terpenes that were already present in the grapes, grain or hops. The second is heterologous biosynthesis — yeast engineered to build terpenes (and even cannabinoids) from sugar, from the ground up, in a steel tank. This page covers both, and then compares yeast-made terpenes to the plant- and cannabis-made terpenes on the Terpenes and Hops pages, because that comparison is the whole reason the operator wanted this written.

Yeast makes its own terpenes

Fungi, including Saccharomyces cerevisiae (brewer's and baker's yeast), run the MVA (mevalonate) pathway in the cytosol — the same pathway that feeds sesquiterpene and sterol synthesis in plants and animals (see Terpenes). Yeast uses it chiefly to make ergosterol, its membrane sterol, and in doing so it produces the universal five-carbon building blocks (IPP and DMAPP) and the prenyl-diphosphate intermediates GPP and FPP. Natively, wild and brewing yeasts throw off small amounts of terpene-adjacent volatiles and, importantly, the C13-norisoprenoids and monoterpene alcohols that shape wine and beer aroma. So a yeast cell is already a working terpene factory at low throughput — it simply spends almost all of its flux on ergosterol instead of on aroma compounds. Metabolic engineering (below) is largely the art of redirecting that existing MVA flux away from sterols and toward a terpene you want.

Biotransformation: yeast unlocking plant terpenes

Much of the "terpene" character in fermented drinks is not made by the yeast de novo and is not free in the fruit either — it is bound, chemically locked to sugars as odourless glycosides in the grape or hop. Fermenting yeast carries glycosidase enzymes (β-glucosidase and others) that cleave these bonds and liberate the free, volatile terpene, turning a scentless precursor into perceptible aroma. This is why fermentation can smell more intensely of terpenes than the starting fruit did.

Wine. Muscat and Gewürztraminer grapes are loaded with glycosidically bound monoterpenes — linalool, geraniol, nerol, citronellol. Yeast and enzyme glycosidase activity during and after fermentation releases them, which is a major lever winemakers and yeast-strain selection act on. Yeast also interconverts these: it can reduce geraniol to citronellol, or cyclise linalool, shifting the aroma profile measurably.
Beer and dry hopping. This is the direct hop connection. When live yeast is present during dry hopping, it biotransforms hop-derived compounds — notably cleaving bound monoterpenes and reducing/rearranging geraniol into citronellol and other forms — a phenomenon brewers call "biotransformation" and deliberately exploit to intensify and shift hop aroma. The terpenes started in the hop (see Hops); the yeast rewrote them.
The general principle. Yeast is both a releaser (glycosidase) and a modifier (reductase/isomerase) of plant terpenes. The finished aroma of a fermented product is a collaboration between the plant's terpene inventory and the yeast's enzyme kit — which is also a theme of Fermentation.

Heterologous biosynthesis: terpenes (and cannabinoids) from sugar

The more dramatic story is engineering yeast to build a target terpene from glucose, with no plant in the loop. Because yeast already runs the MVA pathway, it is the preferred chassis: you overexpress the pathway enzymes to boost the IPP/DMAPP and FPP supply, knock down the competing ergosterol drain, and install one or more plant terpene synthase genes to fold the prenyl-diphosphate into the terpene you want. The result is fermentation-derived terpene, chemically identical to the plant molecule.

Artemisinic acid / artemisinin. The landmark proof of concept: Jay Keasling's group engineered yeast to produce artemisinic acid (a sesquiterpene precursor of the antimalarial artemisinin) at industrial titre, commercialised by Amyris and Sanofi. It showed that a complex plant terpenoid could be made by fermentation at scale.
Farnesene. Amyris engineered yeast to overproduce the sesquiterpene β-farnesene from sugar at very large scale, sold as a renewable base for diesel, lubricants, and (hydrogenated to squalane) cosmetics. This is the clearest example of a "yeast terpene" sold by the tonne.
Monoterpenes (limonene, linalool, geraniol, pinene) have all been produced in engineered yeast and bacteria, though monoterpene titres are generally harder than sesquiterpenes because monoterpenes are more toxic to the cell and the GPP pool is tightly tied to downstream FPP use.
Cannabinoids. This is the headline overlap with the cannabis side of the Library. In 2019 the Keasling lab reported engineered S. cerevisiae producing cannabinoids — including THCA and CBDA and their precursor CBGA — from galactose, by reconstituting the full plant pathway in yeast: the hexanoate-to-olivetolic-acid steps, the prenyltransferase that joins GPP to olivetolic acid to make CBGA, and the oxidocyclase synthases. The significance for this page is that it makes the shared-chemistry point concrete: cannabinoid biosynthesis and terpene biosynthesis draw on the same GPP pool, so a yeast engineered for cannabinoids is running terpene chemistry as its backbone. Companies (Amyris, Ginkgo Bioworks, Demetrix, Cronos, and others) have pursued fermented cannabinoids for exactly this reason — especially the rare cannabinoids (CBG, CBC, THCV) that are scarce in the plant.

Yeast-made versus plant-made versus cannabis-made terpenes

The operator's question — how yeast terpenes compare to marijuana (and to plant terpenes generally) — comes down to a few honest points:

The molecule can be identical. A limonene or a β-caryophyllene made by engineered yeast is the same compound, with the same structure and, if the right enzyme and conditions are used, the same chirality, as the one from citrus or cannabis. "Nature-identical" is literally accurate here. Where it can differ is in the enantiomer ratio and in the trace impurity fingerprint: a plant extract carries dozens of co-occurring terpenes and oxidation products, while a fermentation product is comparatively clean and single-compound unless deliberately blended.
The profile is what cannabis actually has, and yeast does not — yet. Marijuana's effect and aroma come from a blend — a particular ratio of myrcene, limonene, caryophyllene, humulene, linalool and others, layered over the cannabinoids (the "entourage" discussed on Terpenes and in Bioavailability Metabolic Inhibition and Synergy). A single engineered yeast strain makes one terpene well. Reconstructing a full cultivar profile means either blending several single-compound fermentations back together or engineering a multi-synthase strain — which is an active area, not a solved one.
The economics and the politics differ. Fermentation decouples supply from farmland, weather and — importantly for the Library's legal thread — from the agricultural and scheduling regime around the plant. Fermented rare cannabinoids and terpenes can be made consistently and cheaply, which is precisely why the plant-cultivation incumbents and the fermentation companies see each other as competition. The research-monopoly and control-not-ban arguments elsewhere in the Library bear on who is allowed to run this chemistry at all.
"Natural" is doing no real work. Both routes are biosynthesis by a living organism using the same enzymes; the yeast simply hosts the plant's genes. The meaningful questions are purity, chirality, profile completeness and cost — not which kingdom the cell belonged to.

Doing it yourself, honestly

Two tiers are realistic for different readers:

Biotransformation is a home-scale, legal technique. Any homebrewer can exploit yeast biotransformation of hop terpenes: dry-hop while active yeast is still present (during or just after primary fermentation) rather than cold-crashing first, choose a strain documented for biotransformation, and expect the geraniol-to-citronellol and glycoside-release effects described above. This is terpene chemistry you can run in a bucket — see Hops and Fermentation.
Heterologous biosynthesis is laboratory synthetic biology. Building a cannabinoid- or terpene-producing yeast strain requires molecular cloning, selectable markers, pathway balancing and fermentation control — genuine lab work, and for cannabinoids it sits inside the same legal controls as the plant actives. The Library documents the chemistry and the literature; actually running it is an institutional-lab undertaking, and the scheduled-substance pathways carry the legal weight discussed in the cannabis and hemp material.